Article Text

Download PDFPDF

Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries
Free
  1. Francisco Esparza1,
  2. César Cobián2,
  3. José Fernando Jiménez3,
  4. Juan José García-Cota4,
  5. Carlos Sánchez5,
  6. Antonio Maestro6,
  7. the working group for the acute pain study of SETRADE (coordinated by Josep Borrell)
  1. 1Centro Médico Juan XXIII, Murcia, Spain
  2. 2Hospital Modelo, La Coruña, Spain
  3. 3Centro de Medicina General y Deporte, Toledo, Spain
  4. 4Hospital Miguel Domínguez, Pontevedra, Spain
  5. 5Servicios Médicos de la Autoridad Portuaria de Valencia, Spain
  6. 6Sanatorio Begoña, Gijón, Spain and SETRADE (Spanish Society of Sports Traumatology), Barcelona, Spain
  1. Correspondence to:
 Profesor F Esparza
 Cátedra de Traumatología del Deporte, Facultad de Ciencias de la Salud y del Deporte, Universidad Católica San Antonio de Murcia, Campus de los Jerónimos s/n, 30107 Guadalupe (Murcia), Spain; fesparza{at}pdi.ucam.edu

Abstract

Objective: To compare the ketoprofen TDS patch with diclofenac gel in the treatment of traumatic acute pain in benign sport-related soft-tissue injuries.

Design: 7–14 treatment days, prospective, randomised, open study.

Patients: Outpatients aged 18–70 years diagnosed for painful benign sport-related soft-tissue injury (sprains, strains and contusions within the prior 48 h), randomised to either ketoprofen patch 100 mg once daily (n = 114) or diclofenac gel 2–4 g three times daily (n = 109).

Intervention: 7–14 days of topical non-steroidal anti-inflammatory drugs treatment to assess the pain intensity changes (daily activities and spontaneous at rest) in a daily diary (100-mm Visual Analogue Scale (VAS)).

Main outcome measurement: Pain intensity (VAS).

Results: The ketoprofen patch was not inferior to diclofenac gel in reducing the baseline pain during daily activities (difference of –1.17 mm in favour of ketoprofen patch, 95% CI (–5.86 to 3.52), reducing to the baseline VAS 79%. Ketoprofen patch presented also a higher cure rate (64%) than diclofenac gel (46%) at day 7 (p = 0.004). Patient opinions about the treatment comfort (pharmaceutical shape, application and dosage) were also statistically higher for the ketoprofen patch (>80% of the patients rated as good or excellent the patch removal and skin adherence).

Conclusion: Ketoprofen patches are effective and safe pain relievers for the treatment of sports injury pain with advantages compared with diclofenac gel.

  • LOCF, last observation carried forward
  • NSAID, non-steroidal anti-inflammatory drug
  • VAS, Visual Analogue Scale

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 29 November 2006

  • Funding: The study was sponsored by MDS Pharma Services, Madrid, Spain.

  • Competing interests: None declared.